Overview
The Division of Acquired Immunodeficiency Syndrome (DAIDS) was formed in 1986 to develop and implement the national research agenda to address the HIV/AIDS epidemic. Specifically, the mission of DAIDS is to help ensure an end to the HIV/AIDS epidemic by increasing basic knowledge of the pathogenesis and transmission of the human immunodeficiency virus (HIV), supporting the development of therapies for HIV infection and its complications and co-infections, and supporting the development of vaccines and other prevention strategies. DAIDS accomplishes this through planning, implementing, managing, and evaluating programs through the following research programs and offices:
- Basic Sciences Program (BSP)
- Therapeutics Research Program (TRP)
- Vaccine Research Program (VRP)
- Prevention Sciences Program (PSP)
- Office for Policy in Clinical Research Operations (OPCRO)
- Scientific Communications and Information Branch (SCIB)
- Scientific Planning and Operations Branch (SPOB)
- Office of Clinical Site Oversight (OCSO)